Achieve Life Sciences, Inc. (ACHV)
5.43
-0.04
(-0.73%)
USD |
NASDAQ |
Jan 09, 14:12
Achieve Life Sciences Cash from Investing (Quarterly): -12.65M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| StimCell Energetics, Inc. | 0.00 |
| Venus Concept, Inc. | -0.017M |
| Oncolytics Biotech, Inc. | -0.0051M |
| Aurinia Pharmaceuticals, Inc. | -14.04M |
| Edesa Biotech, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.33M |
| Cash from Financing (Quarterly) | 4.042M |
| Free Cash Flow | -40.68M |
| Free Cash Flow Per Share (Quarterly) | -0.2221 |
| Free Cash Flow to Equity (Quarterly) | -11.33M |
| Free Cash Flow to Firm (Quarterly) | -11.14M |
| Free Cash Flow Yield | -19.34% |